Abstract

In biofilms, the bacterial community optimizes the strategies to sense the environment and to communicate from cell to cell. A key player in the development of a bacterial biofilm is the second messenger c-di-GMP, whose intracellular levels are modulated by the opposite activity of diguanylate cyclases and phosphodiesterases. Given the huge impact of bacterial biofilms on human health, understanding the molecular details of c-di-GMP metabolism represents a critical step in the development of novel therapeutic approaches against biofilms. In this study, we present a detailed biochemical characterization of two c-di-GMP phosphodiesterases of the HD-GYP subtype from the human pathogen Pseudomonas aeruginosa, namely PA4781 and PA4108. Upstream of the catalytic HD-GYP domain, PA4781 contains a REC domain typical of two-component systems, while PA4108 contains an uncharacterized domain of unknown function. Our findings shed light on the activity and catalytic mechanism of these phosphodiesterases. We show that both enzymes hydrolyse c-di-GMP in a two-step reaction via the linear intermediate pGpG and that they produce GMP in vitro at a surprisingly low rate. In addition, our data indicate that the non-phosphorylated REC domain of PA4781 prevents accessibility of c-di-GMP to the active site. Both PA4108 and phosphorylated PA4781 are also capable to use pGpG as an alternative substrate and to hydrolyse it into GMP; the affinity of PA4781 for pGpG is one order of magnitude higher than that for c-di-GMP. These results suggest that these enzymes may not work (primarily) as genuine phosphodiesterases. Moreover, the unexpected affinity of PA4781 for pGpG may indicate that pGpG could also act as a signal molecule in its own right, thus further widening the c-di-GMP-related signalling scenario.

Highlights

  • C-di-GMP (3'–5'-diguanylic acid) is a ubiquitous intracellular second messenger, which is crucial for the physiology and pathogenesis of a variety of bacteria, including those of clinical relevance

  • The activity of PA4108 as a c-di-GMP-specific PDE was analysed by a complementation assay using a mutant strain (AB1548) of E. coli lacking the endogenous phosphodiesterase yhjH; AB1548 is characterized by higher levels of c-di-GMP

  • The overexpression of PA4108 into the E. coli AB1548 mutant strain results in a significant decrease of c-di-GMP intracellular levels, restoring the levels observed in the control strain (AB472)

Read more

Summary

Introduction

C-di-GMP (3'–5'-diguanylic acid) is a ubiquitous intracellular second messenger, which is crucial for the physiology and pathogenesis of a variety of bacteria, including those of clinical relevance. The switch from the planktonic to the sessile way of life (typical of biofilms) is achieved when, in response to environmental stimuli, the intracellular levels of c-di-GMP reach a threshold inducing the expression of key genes, as well as the formation of extracellular polymeric substance [6,8,9]. DGCs are called GGDEF proteins after their conserved active site motif; on the other hand, PDEs contain EAL or HD-GYP domains [10,11,12]. The significance of having two types of unrelated c-di-GMP hydrolases in the bacterial genomes is still matter of debate [14], considering that HD-GYP PDEs are not ubiquitous

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call